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Introduction
Gastric cancer is the cause of cancer-related mortality 
in the world. It is the fourth most frequent cancer while 
is the second most common cause of cancer death (1). 
However, American Cancer Society has estimated that 
stomach cancer affects 21,600 new cases in the USA 
in 2013 (2). This disease had more prevalence in Asian 
populations, including Korea, Japan, and China (3). 
Despite considerable improvements in surgical, chemo, 
radio and other adjuvant therapies, the five-year survival 
rate of patients at the advanced stage remains less than 20 
to 25% (4,5). Recently, regulation of oncogenesis that is 
grip of eukaryotic translation initiation factor 4E (eIF4E), 
has been considered by many researchers. eIF4E is one of 
the subunits of eIF4F complex which recognizes the 5′ cap 
structure of spectrum mRNAs involving in angiogenesis, 
metastasis and cell growth (6) which is activated via PI3K/
AKT signaling pathway (7,8). Recently, there have been 
many reports on the elevated levels of eIF4E in various 
human cancers such as human gastric cancer cell lines (9). 
Hence, expression of this factor may be a potential target 
for therapeutic purpose for cancer.
Implication for health policy/practice/research/medical education:
Chrysin and caffeic acid phenethyl ester – two components of propolis decreases eukaryotic translation initiation factor 4E (eIF4E) 
gene expression and might be useful in developing chemotherapeutic agents for treating human gastric cancer.
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Introduction: The Ras/Akt/mTORC1 signal transduction pathways play a critical role in 
regulating translation and converge on initiation factor eukaryotic translation initiation factor 4E 
(eIF4E) which is overexpressed in various malignancies. In the current study we aimed to assess 
the effect of chrysin and caffeic acid phenethyl ester (CAPE) on eIF4E expression level in human 
stomach cancer AGS cell line.
Methods: AGS cells were treated with 15, 20, 30 and 40 μM concentration of chrysin and   CAPE 
separately, then eIF4E expression was evaluated in treated cells using real time-PCR method.  
Results: A significant decrease in eIF4E expression in the cells following 40 µM chrysin treatment 
was observed (p<0.05). There was a significant decrease in CAPE-treated cells in a dose dependent 
manner. Indeed the cells treated with 30 and 40 µM concentrations of CAPE, showed a significant 
decline in eIF4E expression (p<0.05).
Conclusion: Our results suggest that CAPE and chrysin may be useful as a potential therapeutic 
agent for treatment of gastric cancers with an elevated eIF4E expression level.
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Chrysin and Caffeic Acid Phenyl Ster (CAPE) are 
two components of propolis. This components have 
important biological roles. It has been proposed that 
propolis components such as chrysin and CAPE could be 
potential candidate agents in treatment of cancer due to 
their beneficial anticancer properties (10-12). It has been 
demonstrated before that Chrysin and CAPE may have an 
anti-cancer properties because of apoptotic induction and 
inactivation of PI3K/Akt pathways effects (13-15).
Many studies have reported an elevated activity of PI3K/
Akt pathways and expression of eIF4E in cancer cells 
(9,16) and it has been proposed that chrysin may inactive 
PI3K/Akt signaling pathway through down-regulation of 
NF-kB pathway and conversely, activating of IAP. Thus, 
it might play an important role in apoptosis induction by 
promoting caspase-3 activity (15). Moreover, U937 cells 
treated by chrysin have shown an increased cytochrome c 
release from the mitochondria into cytosol (15).
CAPE and Chrysin activate several caspases, they inhibit 
PI3K/Akt signal pathway, IAP, c-FLIP (anti-apoptotic 
proteins), and lead to suppress in the activity of IKK and 
NF-kB (11,12). Considering multiple beneficial effects 
of CAPE and Chrysin in apoptosis and down-regulating 
of eIF4E, we conducted an experiment to evaluate eIF4E 
mRNA expression with this component in gastric cancer 
AGS cell line.
Materials and Methods
Cell culture and treatment
In this experimental study, the human AGS cell line 
was obtained from Royan institute and was cultured in 
DMEM supplemented with 10% FBS and 1% Penicillin-
streptomycin.
IC50 was determined in AGS cells following incubation 
a serial dilutions of chrysin (Sigma Aldrich cat#:C80105) 
and CAPE (Sigma Aldrich cat#:C8221) separately for 
48 h. Then AGS cells were treated with Chrysin and 
CAPE  in four concentration 15, 20, 30 and 40 μM for 48 
h in triplicate.
RNA extraction and cDNA synthesize
Total RNA was extract using Biozol (cat# BSC51M1) 
according Kit protocol. RNA concentration was measured 
by NanoDrop1000 UV-Vis spectrophotometer (Thermo 
Scientific Inc., USA). Then, cDNA was synthesized 
according to the manufacturer’s instructions (Thermo 
Scientific Inc., USA).
Real time PCR assay
Real time-PCR was performed using Rotor-Gene 3000 
(Corbett Robotics, Australia), Maxima SYBR Green/Rox 
qPCR Master Mix (Thermo Scientific Inc., USA) and 
specific primers. Primer sequences for eIF4E were: sense 
5′-CCTACAGAAC AGATGGGCACTC-3′, antisense 
5′-GCCCAAAAGTCTTCAACAGTATCA-3’ (6) and 
for GAPDH was sense: 5′-TTCACCACCATGGAGA-
AGGC-3′  RW: 5′-CCCTTTTGGCTC CACCCT-3′.
Each reaction was performed in a final 25 µl mixture 
containing 12.5 µl of Maxima SYBR Green/Rox qPCR 
Master Mix, 2 µl of each primers, 11.1 µl of DEPC Treated 
Water and 1 µl cDNA. Thermal cycling was performed as 
described herein: initial denaturation for 10 min at 95 ºC; 
followed by 40 cycles of 95 ºC for 30 s, 57 ºC for 30 s and 
72 ºC for 30 s. 
The melting carve plot profile of real time PCR product 
was: Ramp from 72 degrees to 95 degrees, Rising by 1 
degree(s) each step, Wait for 45 s on first step, then Wait 
for 5 s on for each step after wards Acquire to Melt A 
on FAM/ SYBR. eIF4E expression was normalized with 
GAPDH mRNA and relative expression analyzed using 
ΔΔCt method.
Statistics analysis
The results were expressed as mean ± SD and statistical 
analyses were done using GraphPad Prism software 
(v5.01, USA) and Kruskal-Wallis tests followed by post 
hoc comparisons, Dunn’s multiple comparison. 
Results
Effect of Chrysin on eIF4E
Different chyrsin concentrations ranging around IC50 
dose were used to evaluate the effect of chyrsin on 
expression of eIF4E. 
As it is shown in Figure 1 expression of eIF4E was not 
significantly altered by 15, 20 and 30 µM concentrations 
of chrysin, whereas concentration of 40 µM markedly 
decreased eIF4E expression in AGS cells (3.84-
fold, p≤0.05).
Effect of CAPE on eIF4E
The effect of CAPE on AGS cells is shown in Figure 2, 
expression of eIF4E was not significantly altered by 10, 15, 
and 20 concentrations of CAPE, whereas concentration 
of 30 and 40 µM noticeable decreased eIF4E expression 
in CAPE treated AGS cells (3.03-fold, p≤ 0.05 for 
Figure 1. The effect of chrysin on eIF4E expression in AGS cells. 
The data are expressed as means ± SD and (*) p≤ 0.05 compared 
with the corresponding value of control group.
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30 µl concentration and 2.85-fold, p≤ 0.05 for 40 µl 
concentration).
Discussion
Here we showed that eIF4E mRNA was down-regulated 
in AGS cells after chrysin or caffeic acid treatment. Many 
studies have shown the eIF4E up-regulation in various 
cancers such as gastric, prostate, breast, colon, lung 
and skin cancers (9,17-24). However, eIF4E regulates a 
set of oncogenes which control proliferation including 
CMYC, CDK2, Cyclin D1 or oncogenes that involved in 
metastasis such as MMP9 and Heparanase or oncogenes 
that play roles in invasion and angiogenesis like Mcl-1, 
Bcl-2, Survivin ,VEGF and FGF2 (7,8).
A previous study by Liang et al has shown that eIF4E was 
increased in different gastric cancer cells including AGS 
cell line which may involve in vascular invasion (9).
Furthermore, recent studies have provided evidence that 
chrysin activates Bax, p53, p21 caspases and p38 MAPK 
and conversely deactivates NF-ҡB pathway. Therefore, 
inhibition of IAP, c-FLIP and Akt activity derived by 
chrysin and caffeic acid may induce extrinsic pathway of 
apoptosis (11,12).
Targeting of eIF4E by ribavirin which compete with 
eIF4E for coupling to the m7G cap and therefore blocks 
eIF4E activity, led to a relative improvement in patients 
with acute myeloid leukemia (25). Considering the fact 
that Bcl2 and several capases are downstream targets of 
eIF4E and suppressing effects of chrysin and caffeic acid 
on eIF4E expression, our results support the notion that 
chrysin and caffeic acid may have anti-cancer effects by 
inducing apoptosis in cancer cells. 
It has been previously shown that chrysin significantly 
suppressed migration and invasion of triple-negative 
breast cancer cells (26). Moreover, it was previously 
demonstrated by Samarghandian et al that chrysin restrain 
the development of lung cancer cells. They notify that 
chrysin induces apoptosis in cancer cells via regulation of 
the Bcl-2 family, caspase-3 and -9 (27).
A previous report by Lirdprapamongkol et al indicated a 
Figure 2. The effect of CAPE on eIF4E expression in AGS cells. 
The data are expressed as means ± SD and (*) p≤ 0.05 compared 
with the corresponding value of control group.
remarked over expression of VEGF in mouse T14 breast 
cancer cells led to resistance of these cells to apoptosis. 
This study showed that antimetastsic activity of DR5mAb 
was increased when it used with chrysin (28). 
In one study that was performed by Chung et al, they 
suggest that the antimetastatic and anti-tumor effects of 
CAPE are mediated through the selective suppression 
of MMP-9 enzyme activity and transcriptional down-
regulation by the dual inhibition of NF-ҡB as well as 
MMP-9 catalytic activity (29). The MMP-9 is one of 
eIF4E targets therefore our results that show decline of 
eIF4E expression in CAPE treatment cells, confirm the 
antimetastatic role of this companant. 
Two other studies was shown that CAPE inhibits the NF-
ҡB factor which Augments the susceptibility of intestinal 
epithelial cells to anticancer drugs. So, these studies 
present CAPE to be an effective assistant of chemotherapy 
and augment therapeutic efficacy therefore it can decline 
chemotherapy-induced toxicities (30,31).
Murtaza et al suggest  that CAPE is an effective inhibitor 
of NF-ҡB and a stimulator of the functions of glutathione 
S-transferase, it drains GSH levels. Subsequently, tumor 
cells are radiosensitized due to this drainage (32).
With regards the co-relation of eIF4E expression with 
cancer incidence and our observations suggest that 
chrysin and caffeic acid might be promising treatments 
for cancer which may improve many aspects of cancer 
such as angiogenesis and metastasis derived by down-
regulating of eIF4E expression. Moreover, since eIF4E as 
a key components of AKT pathway, was down-regulated 
by both chrysin and caffeic acid, this suggests that chrysin 
and caffeic acid could be useful in cancer treatment due 
to their suppressive effect on AKT signaling. The exact 
mechanism underlying the down-regulating effects of 
chrysin and caffeic acid on eIF4E expression remained 
to be elucidated. To the best of our knowledge, there are 
no previous report about the down-regulating effects of 
chrysin or caffeic acid on eIF4E.
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